155 related articles for article (PubMed ID: 38570641)
1. Author Correction: In‑silico study of drug delivery to atherosclerosis in the human carotid artery using metal-organic frameworks based on adhesion of nanocarriers.
Shamloo A; Naseri T; Rahbary A; Bakhtiari MA; Ebrahimi S; Mirafzal I
Sci Rep; 2024 Apr; 14(1):7868. PubMed ID: 38570641
[No Abstract] [Full Text] [Related]
2. In-silico study of drug delivery to atherosclerosis in the human carotid artery using metal-organic frameworks based on adhesion of nanocarriers.
Shamloo A; Naseri T; Rahbary A; Bakhtiari MA; Ebrahimi S; Mirafzal I
Sci Rep; 2023 Dec; 13(1):21481. PubMed ID: 38057414
[TBL] [Abstract][Full Text] [Related]
3. Targeted drug delivery in pulmonary therapy based on adhesion and transmission of nanocarriers designed with a metal-organic framework.
Ranjbar H; Farajollahi A; Rostami M
Biomech Model Mechanobiol; 2023 Dec; 22(6):2153-2170. PubMed ID: 37624467
[TBL] [Abstract][Full Text] [Related]
4. Functional metal-organic framework-based nanocarriers for accurate magnetic resonance imaging and effective eradication of breast tumor and lung metastasis.
Meng Z; Huang H; Huang D; Zhang F; Mi P
J Colloid Interface Sci; 2021 Jan; 581(Pt A):31-43. PubMed ID: 32768733
[TBL] [Abstract][Full Text] [Related]
5. Metal-Organic Frameworks Nanocarriers for Functional Nucleic Acid Delivery in Biomedical Applications.
He L; Shang M; Chen Z; Yang Z
Chem Rec; 2023 Jun; 23(6):e202300018. PubMed ID: 36912736
[TBL] [Abstract][Full Text] [Related]
6. Novel formulations of metal-organic frameworks for controlled drug delivery.
Rao C; Liao D; Pan Y; Zhong Y; Zhang W; Ouyang Q; Nezamzadeh-Ejhieh A; Liu J
Expert Opin Drug Deliv; 2022 Oct; 19(10):1183-1202. PubMed ID: 35426756
[TBL] [Abstract][Full Text] [Related]
7. Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents.
Liu W; Ma X; Kheyr SM; Dong A; Zhang J
Materials (Basel); 2022 Oct; 15(20):. PubMed ID: 36295281
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
Fatima SF; Sabouni R; Garg R; Gomaa H
Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Metal-Organic-Framework-Based Nanocarriers for Controllable Drug Delivery and Release.
Zong Z; Tian G; Wang J; Fan C; Yang F; Guo F
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559283
[TBL] [Abstract][Full Text] [Related]
10. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
[TBL] [Abstract][Full Text] [Related]
11. Metal-Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications.
Sun Y; Zheng L; Yang Y; Qian X; Fu T; Li X; Yang Z; Yan H; Cui C; Tan W
Nanomicro Lett; 2020 May; 12(1):103. PubMed ID: 34138099
[TBL] [Abstract][Full Text] [Related]
12. Progress of Stimuli-Responsive Nanoscale Metal Organic Frameworks as Controlled Drug Delivery Systems.
Feng A; Wang Y; Ding J; Xu R; Li X
Curr Drug Deliv; 2021; 18(3):297-311. PubMed ID: 32940178
[TBL] [Abstract][Full Text] [Related]
13. Advances and Applications of Metal-Organic Framework Nanomaterials as Oral Delivery Carriers: A Review.
Li L; Qi Z; Han S; Li X; Liu B; Liu Y
Mini Rev Med Chem; 2022; 22(20):2564-2580. PubMed ID: 35362373
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of biological macromolecules double emulsion based on carboxymethylcellulose/gelatin hydrogel incorporated with ZIF-8 as metal organic frameworks for sustained anti-cancer drug release.
Pourmadadi M; Aslani A; Abdouss M
Int J Biol Macromol; 2023 Jul; 243():125168. PubMed ID: 37270138
[TBL] [Abstract][Full Text] [Related]
15. A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment.
Xu Z; Wu Z; Huang S; Ye K; Jiang Y; Liu J; Liu J; Lu X; Li B
J Control Release; 2023 Feb; 354():615-625. PubMed ID: 36641123
[TBL] [Abstract][Full Text] [Related]
16. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
17. MOF-based stimuli-responsive controlled release nanopesticide: mini review.
Hu S; Yan C; Fei Q; Zhang B; Wu W
Front Chem; 2023; 11():1272725. PubMed ID: 37767340
[TBL] [Abstract][Full Text] [Related]
18. Hybrid liposome/metal-organic framework as a promising dual-responsive nanocarriers for anticancer drug delivery.
Karami A; Ahmed A; Sabouni R; Husseini GA; Sharabati MA; AlSawaftah N; Paul V
Colloids Surf B Biointerfaces; 2022 Sep; 217():112599. PubMed ID: 35714509
[TBL] [Abstract][Full Text] [Related]
19. Metal-Organic Framework (MOF)-Based Drug Delivery.
Cao J; Li X; Tian H
Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
[TBL] [Abstract][Full Text] [Related]
20. Metal-Organic Frameworks as Intelligent Drug Nanocarriers for Cancer Therapy.
Cai X; Bao X; Wu Y
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
